Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The clinical perspective on late-onset depression in European real-world treatment settings.
Bartova L, Fugger G, Dold M, Kautzky A, Bairhuber I, Kloimstein P, Fanelli G, Zanardi R, Weidenauer A, Rujescu D, Souery D, Mendlewicz J, Zohar J, Montgomery S, Fabbri C, Serretti A, Kasper S. Bartova L, et al. Among authors: dold m. Eur Neuropsychopharmacol. 2024 Apr 27;84:59-68. doi: 10.1016/j.euroneuro.2024.03.007. Online ahead of print. Eur Neuropsychopharmacol. 2024. PMID: 38678879 Free article.
Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders.
Groppa S, Gonzalez-Escamilla G, Tinkhauser G, Baqapuri HI, Sajonz B, Wiest C, Pereira J, Herz DM, Dold MR, Bange M, Ciolac D, Almeida V, Neuber J, Mirzac D, Martín-Rodríguez JF, Dresel C, Muthuraman M, Adarmes Gomez AD, Navas M, Temiz G, Gunduz A, Rotaru L, Winter Y, Schuurman R, Contarino MF, Glaser M, Tangermann M, Leentjens AFG, Mir P, Torres Diaz CV, Karachi C, Linden DEJ, Tan H, Coenen VA; EuroDBS. Groppa S, et al. Among authors: dold mr. Stereotact Funct Neurosurg. 2024;102(1):40-54. doi: 10.1159/000535114. Epub 2023 Dec 12. Stereotact Funct Neurosurg. 2024. PMID: 38086346 Free article. Review.
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Clinical Trial.
Competition and moral behavior: A meta-analysis of forty-five crowd-sourced experimental designs.
Huber C, Dreber A, Huber J, Johannesson M, Kirchler M, Weitzel U, Abellán M, Adayeva X, Ay FC, Barron K, Berry Z, Bönte W, Brütt K, Bulutay M, Campos-Mercade P, Cardella E, Claassen MA, Cornelissen G, Dawson IGJ, Delnoij J, Demiral EE, Dimant E, Doerflinger JT, Dold M, Emery C, Fiala L, Fiedler S, Freddi E, Fries T, Gasiorowska A, Glogowsky U, M Gorny P, Gretton JD, Grohmann A, Hafenbrädl S, Handgraaf M, Hanoch Y, Hart E, Hennig M, Hudja S, Hütter M, Hyndman K, Ioannidis K, Isler O, Jeworrek S, Jolles D, Juanchich M, Kc RP, Khadjavi M, Kugler T, Li S, Lucas B, Mak V, Mechtel M, Merkle C, Meyers EA, Mollerstrom J, Nesterov A, Neyse L, Nieken P, Nussberger AM, Palumbo H, Peters K, Pirrone A, Qin X, Rahal RM, Rau H, Rincke J, Ronzani P, Roth Y, Saral AS, Schmitz J, Schneider F, Schram A, Schudy S, Schweitzer ME, Schwieren C, Scopelliti I, Sirota M, Sonnemans J, Soraperra I, Spantig L, Steimanis I, Steinmetz J, Suetens S, Theodoropoulou A, Urbig D, Vorlaufer T, Waibel J, Woods D, Yakobi O, Yilmaz O, Zaleskiewicz T, Zeisberger S, Holzmeister F. Huber C, et al. Among authors: dold m. Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2215572120. doi: 10.1073/pnas.2215572120. Epub 2023 May 30. Proc Natl Acad Sci U S A. 2023. PMID: 37252958 Free PMC article.
Age as a moderating factor of treatment resistance in depression.
Kautzky A, Bartova L, Fugger G, Dold M, Souery D, Montgomery S, Zohar J, Mendlewicz J, Fabbri C, Serretti A, Rujescu D, Kasper S. Kautzky A, et al. Among authors: dold m. Eur Psychiatry. 2023 Apr 20;66(1):e35. doi: 10.1192/j.eurpsy.2023.17. Eur Psychiatry. 2023. PMID: 37078509 Free PMC article.
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder.
Bartova L, Fugger G, Dold M, Kautzky A, Fanelli G, Zanardi R, Albani D, Weidenauer A, Rujescu D, Souery D, Mendlewicz J, Montgomery S, Zohar J, Fabbri C, Serretti A, Kasper S. Bartova L, et al. Among authors: dold m. J Affect Disord. 2023 Jul 1;332:105-114. doi: 10.1016/j.jad.2023.03.068. Epub 2023 Mar 22. J Affect Disord. 2023. PMID: 36958488 Free article.
Silexan for treatment of anxiety and depression in the context of COVID-19.
Bartova L, Dold M, Fugger G, Weidenauer A, Rujescu D, Kasper S. Bartova L, et al. Among authors: dold m. Eur Neuropsychopharmacol. 2023 May;70:47-48. doi: 10.1016/j.euroneuro.2023.02.015. Epub 2023 Feb 23. Eur Neuropsychopharmacol. 2023. PMID: 36867894 Free PMC article. No abstract available.
75 results